Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection
Crossref DOI link: https://doi.org/10.1186/s40425-017-0277-7
Published Online: 2017-09-19
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Garcia-Carbonero, Rocio
Salazar, Ramon
Duran, Ignacio
Osman-Garcia, Ignacio
Paz-Ares, Luis
Bozada, Juan M.
Boni, Valentina
Blanc, Christine
Seymour, Len
Beadle, John
Alvis, Simon
Champion, Brian
Calvo, Emiliano
Fisher, Kerry
Funding for this research was provided by:
PsiOxus Limited